PMC:7652766 / 96891-97247 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T474","span":{"begin":0,"end":356},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A recent retrospective multicenter cohort study of 446 Chinese patients with COVID-19 reported that among severe to critical COVID-19 patients, early administration (≤5 days after admission) of IFN-α2b decreased mortality in comparison with no admission of IFN-α2b, whereas no significant benefit was associated with IFN-α2b use in moderately ill patients."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3542","span":{"begin":194,"end":201},"obj":"Gene"},{"id":"3543","span":{"begin":257,"end":264},"obj":"Gene"},{"id":"3544","span":{"begin":317,"end":324},"obj":"Gene"},{"id":"3547","span":{"begin":113,"end":115},"obj":"Gene"},{"id":"3548","span":{"begin":63,"end":71},"obj":"Species"},{"id":"3549","span":{"begin":134,"end":142},"obj":"Species"},{"id":"3550","span":{"begin":347,"end":355},"obj":"Species"},{"id":"3552","span":{"begin":0,"end":1},"obj":"Gene"},{"id":"3553","span":{"begin":77,"end":85},"obj":"Disease"},{"id":"3554","span":{"begin":125,"end":133},"obj":"Disease"},{"id":"3555","span":{"begin":212,"end":221},"obj":"Disease"}],"attributes":[{"id":"A3542","pred":"tao:has_database_id","subj":"3542","obj":"Gene:3440"},{"id":"A3543","pred":"tao:has_database_id","subj":"3543","obj":"Gene:3440"},{"id":"A3544","pred":"tao:has_database_id","subj":"3544","obj":"Gene:3440"},{"id":"A3547","pred":"tao:has_database_id","subj":"3547","obj":"Gene:6999"},{"id":"A3548","pred":"tao:has_database_id","subj":"3548","obj":"Tax:9606"},{"id":"A3549","pred":"tao:has_database_id","subj":"3549","obj":"Tax:9606"},{"id":"A3550","pred":"tao:has_database_id","subj":"3550","obj":"Tax:9606"},{"id":"A3552","pred":"tao:has_database_id","subj":"3552","obj":"Gene:351"},{"id":"A3553","pred":"tao:has_database_id","subj":"3553","obj":"MESH:C000657245"},{"id":"A3554","pred":"tao:has_database_id","subj":"3554","obj":"MESH:C000657245"},{"id":"A3555","pred":"tao:has_database_id","subj":"3555","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A recent retrospective multicenter cohort study of 446 Chinese patients with COVID-19 reported that among severe to critical COVID-19 patients, early administration (≤5 days after admission) of IFN-α2b decreased mortality in comparison with no admission of IFN-α2b, whereas no significant benefit was associated with IFN-α2b use in moderately ill patients."}